Connection
Jessica Hellyer to Consolidation Chemotherapy
This is a "connection" page, showing publications Jessica Hellyer has written about Consolidation Chemotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.178 |
|
|
|
-
Aredo JV, Hellyer JA, Neal JW, Wakelee HA. Consolidation Durvalumab Should Not Be Administered to Patients With Stage III EGFR-Mutant NSCLC. J Thorac Oncol. 2021 12; 16(12):1994-1998.
Score: 0.178